BBNX ▲ +0.7% - Beta Bionics, Inc. $BBNX - Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365 Beta Bionics shares rose 0.7% following the company's announcement of an integration agreement between its iLet Bionic Pancreas and mint platform with Senseonics' Eversense 365 continuous glucose monitoring system. The partnership expands the iLet's compatibility with leading glucose sensing technology, potentially broadening its appeal to diabetes patients already using or considering Eversense for monitoring. 22-SEP-2026 07:30 AM ET